Quantum Dots in Biomedical Imaging and Drug Delivery

Quantum dots are semiconductor nanocrystals with diameters below 10 nm, whose electronic and optical properties can be precisely tuned via size and composition. They display broad absorption and narrow emission spectra, high quantum yields and exceptional resistance to photobleaching, features that render them superior to traditional organic fluorophores for fluorescence-based imaging at cellular and organismal levels. Surface engineering strategies, including zwitterionic and polyethylene glycol coatings, have improved their biocompatibility and prolonged circulation, while reducing immunogenicity. In parallel, quantum dots have emerged as versatile drug delivery vehicles: their cores or surface ligands can bind or encapsulate chemotherapeutic agents, nucleic acids or proteins, enabling targeted transport and controlled release in response to pH, enzymatic activity or redox potential in diseased tissues. The integration of imaging and therapeutic functions into a single nanosystem supports theranostic approaches, offering simultaneous diagnostics and treatment. These developments promise more sensitive disease detection, real-time monitoring of therapeutic distribution and tailored payload release, with significant implications for oncology, neurology and cardiovascular interventions.

Research from Nature Portfolio

Recent studies have reported the design of near-infrared-emitting quantum dots coated with zwitterionic ligands that demonstrate deep-tissue penetrance and minimal nonspecific uptake, enabling high-contrast imaging of subcutaneous and orthotopic tumours. Another investigation introduced biodegradable polymer shells surrounding cadmium-free quantum dots that undergo accelerated degradation in acidic endosomal compartments, achieving on-demand release of anticancer drugs while preserving fluorescence for tracking intracellular trafficking. A further advance combined quantum dots with CRISPR–Cas gene editors to create a dual-modal platform capable of real-time imaging of gene delivery and expression in live models, thereby facilitating direct observation of genetic intervention efficacy.

Quantum Dots in Biomedical Imaging and Drug Delivery publication trend

The graph below shows the total number of articles in quantum dots in biomedical imaging and drug delivery across all publications each year (not limited to Nature Index journals).

Technical terms

Quantum confinement: The phenomenon by which charge carriers in a nanocrystal experience spatial restriction, leading to discrete energy levels and size-dependent optical properties.

Photoluminescence: Emission of light from a material following absorption of photons, a key property for imaging contrast in quantum dots.

Surface functionalisation: Chemical modification of nanoparticle surfaces with ligands or polymers to impart biocompatibility, targeting and stealth properties in biological environments.

Photobleaching: Irreversible loss of fluorophore emission upon prolonged illumination; quantum dots exhibit enhanced resistance to this effect.

Theranostics: A combined therapeutic and diagnostic approach that integrates treatment delivery with real-time monitoring of its efficacy using the same platform.

References

1. Quantum Dots and Their Multimodal Applications: A Review. Materials (2010).
2. Quantum dots: synthesis, bioapplications, and toxicity. Discover Nano (2012).
3. Quantum Dots for Live Cell and In Vivo Imaging. International Journal of Molecular Sciences (2009).
4. Quantum Dots — Characterization, Preparation and Usage in Biological Systems. International Journal of Molecular Sciences (2009).
5. The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy. Discover Nano (2016).